MedPath

Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women

Completed
Conditions
Infertility
Registration Number
NCT03160872
Lead Sponsor
Institut Universitari Dexeus
Brief Summary

To evaluate if ovarian reserve (measured by means of anti-mullerian hormone -AMH- and antral follicle count -AFC-) can predict pregnancy in donor insemination cycles (dIUI) performed in non-infertile women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
143
Inclusion Criteria
  • absence of male partner
  • complete azoospermia or the presence of a genetic condition in the partner that made the couple opt for donor sperm
  • absence of previous history of infertility.
  • d ta on AMH and AFC assessment before the first dIUI cycle.
Exclusion Criteria
  • previous history of infertility.

  • Presence of any gynaecological condition that could impair the inseminations results:

    • endometriosis, hydrosalpinx,...

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Pregnancy6 weeks after insemination procedure

Clinical Pregnancy evaluated by ultrasound with fetal heart beat

Secondary Outcome Measures
NameTimeMethod
Miscarriage rateEvaluated until 15 weeks after insemination procedure

Number of clinical miscarriage after clinical pregnancy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.